UNSPSC 41181547: Low-density lipoprotein immunological test system

In this classification, a Low-density lipoprotein immunological test system is a device that consists of the reagents used to identify by immunochemical techniques Low-density lipoprotein. US FDA regulates Low-density lipoprotein immunological test system under 21 CFR 866.5600 and under FDA product code DFC.

UNSPSC 41181547 Low-density lipoprotein immunological test system is a Commodity code with minimal recent state and local procurement activity directly aligned to the code's nominal scope. The recent opportunities posted under this code do not substantiate active solicitation for LDL immunological test systems or related diagnostic reagents; instead, the tagged opportunities span laboratory service contracting, equipment repair and maintenance, spectrophotometer procurement, oil testing services, landscape architecture, and other unrelated goods and services. The code shows little evidence of state or local government demand for the specific product class it names.

The source records no recent solicitations for LDL immunological test systems or equivalent diagnostic testing equipment from state or local issuing bodies. The mismatch between the code's nominal scope and the actual opportunities posted under it suggests either tagging error in the procurement system or dormant demand for this commodity during the current cycle. A business development professional evaluating this code should treat it as inactive pending clearer evidence of state or local procurement intent for LDL immunological test systems themselves.